Published in J Biol Chem on February 20, 1998
Specialized roles for cysteine cathepsins in health and disease. J Clin Invest (2010) 2.69
Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am J Pathol (2007) 1.43
Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting. Biochem J (2001) 1.23
Activation of human prolegumain by cleavage at a C-terminal asparagine residue. Biochem J (2000) 1.11
Cathepsins L and S are not required for activation of dipeptidyl peptidase I (cathepsin C) in mice. Biol Chem (2006) 0.99
Proteolytic activation of the essential parasitophorous vacuole cysteine protease SERA6 accompanies malaria parasite egress from its host erythrocyte. J Biol Chem (2012) 0.98
The metalloprotease of Listeria monocytogenes is activated by intramolecular autocatalysis. J Bacteriol (2007) 0.97
Expression and characterization of a recombinant cysteine proteinase of Leishmania mexicana. Biochem J (2000) 0.92
Crystal structure and silica condensing activities of silicatein alpha-cathepsin L chimeras. Chem Commun (Camb) (2008) 0.84
Activation mechanism of recombinant Der p 3 allergen zymogen: contribution of cysteine protease Der p 1 and effect of propeptide glycosylation. J Biol Chem (2008) 0.81
The Ionic and hydrophobic interactions are required for the auto activation of cysteine proteases of Plasmodium falciparum. PLoS One (2012) 0.80
Chondroitin sulfate promotes activation of cathepsin K. J Biol Chem (2014) 0.79
Structural basis for specificity of propeptide-enzyme interaction in barley C1A cysteine peptidases. PLoS One (2012) 0.79
Endothelial cells and cathepsins: Biochemical and biomechanical regulation. Biochimie (2015) 0.78
Cysteine Proteases: Modes of Activation and Future Prospects as Pharmacological Targets. Front Pharmacol (2016) 0.76
PACMANS: A Bioinformatically Informed Algorithm to Predict, Design, and Disrupt Protease-on-Protease Hydrolysis. Protein Sci (2017) 0.75
Mutation in the Pro-Peptide Region of a Cysteine Protease Leads to Altered Activity and Specificity-A Structural and Biochemical Approach. PLoS One (2016) 0.75
Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med (1996) 5.77
P-TEFb kinase recruitment and function at heat shock loci. Genes Dev (2000) 4.07
Protein fusions of beta-galactosidase to the ferrichrome-iron receptor of Escherichia coli K-12. J Bacteriol (1986) 2.44
Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol (1998) 2.43
Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci (1991) 2.35
Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore) (1980) 2.26
Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J (1996) 2.24
Ultrasound-guided perineural circumferential median nerve block in carpal tunnel syndrome. Anaesthesia (2013) 1.98
Isolation of a clone coding for the alpha-subunit of a mouse acetylcholine receptor. J Neurosci (1985) 1.80
Aggrecan degradation in human intervertebral disc and articular cartilage. Biochem J (1997) 1.78
Radio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Science (2009) 1.66
Very-high-energy gamma rays from a distant quasar: how transparent is the universe? Science (2008) 1.65
Monoclonal antibodies recognizing protease-generated neoepitopes from cartilage proteoglycan degradation. Application to studies of human link protein cleavage by stromelysin. J Biol Chem (1992) 1.63
Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem J (1995) 1.63
Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology (1993) 1.62
Role of the occluding loop in cathepsin B activity. J Biol Chem (1997) 1.61
Medical repatriation via fixed-wing air ambulance: a review of patient characteristics and adverse events. Anaesthesia (2001) 1.56
Hybridization between transgenic Brassica napus L. and its wild relatives: Brassica rapa L., Raphanus raphanistrum L., Sinapis arvensis L., and Erucastrum gallicum (Willd.) O.E. Schulz. Theor Appl Genet (2003) 1.55
The heterogeneity of link proteins isolated from human articular cartilage proteoglycan aggregates. J Biol Chem (1982) 1.50
African tick-bite fever: a new spotted fever group rickettsiosis under an old name. Lancet (1992) 1.49
Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion. Structure (1996) 1.47
Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis (2007) 1.47
Age-related changes in the structure of proteoglycan link proteins present in normal human articular cartilage. Biochem J (1983) 1.46
Tyrosine 319, a newly identified phosphorylation site of ZAP-70, plays a critical role in T cell antigen receptor signaling. J Biol Chem (1999) 1.45
A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects. Am Rev Respir Dis (1982) 1.44
Rat procathepsin B. Proteolytic processing to the mature form in vitro. J Biol Chem (1992) 1.44
Genetic transformation and phylogeny of bacterial symbionts from tsetse. Insect Mol Biol (1993) 1.44
fhuC and fhuD genes for iron (III)-ferrichrome transport into Escherichia coli K-12. J Bacteriol (1987) 1.41
Structural and functional roles of asparagine 175 in the cysteine protease papain. J Biol Chem (1995) 1.40
Contribution of the glutamine 19 side chain to transition-state stabilization in the oxyanion hole of papain. Biochemistry (1991) 1.40
Variable very-high-energy gamma-ray emission from the microquasar LS I +61 303. Science (2006) 1.40
Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Mol Biochem Parasitol (1992) 1.39
Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet (1994) 1.34
A screening test for airways reactivity. An abbreviated methacholine inhalation challenge. Chest (1982) 1.33
Characterization of a thiol proteinase secreted by malignant human breast tumours. Biochim Biophys Acta (1980) 1.33
The molecular basis of glucose-6-phosphate dehydrogenase deficiency. Trends Genet (1992) 1.33
A protein engineering study of the role of aspartate 158 in the catalytic mechanism of papain. Biochemistry (1990) 1.32
Degradation of proteoglycan aggregate by a cartilage metalloproteinase. Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ. Biochem J (1989) 1.30
Accuracy of routine diagnosis of pulmonary tuberculosis in an area of high HIV prevalence. Int J Tuberc Lung Dis (2004) 1.30
Maturation of human procathepsin B. Proenzyme activation and proteolytic processing of the precursor to the mature proteinase, in vitro, are primarily unimolecular processes. J Biol Chem (1994) 1.29
Value of colposcopy in sexually transmitted diseases clinic based on first year's experience. Genitourin Med (1989) 1.28
Induction of ovulation with pulsatile luteinising hormone releasing hormone. Br Med J (Clin Res Ed) (1984) 1.26
Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry (1996) 1.26
Urease-producing species of intestinal anaerobes and their activities. Appl Environ Microbiol (1979) 1.24
Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B. Biochem J (1990) 1.24
Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. Cytokine (2001) 1.20
Muscle crossbridge stroke and activity revealed by optical diffraction. Science (1978) 1.19
Age-related changes in fibromodulin and lumican in human intervertebral discs. Spine (Phila Pa 1976) (1999) 1.19
Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J (1999) 1.18
Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthritis Rheum (1984) 1.17
Molecular cloning of the ferrichrome-iron receptor of Escherichia coli K-12. J Bacteriol (1983) 1.17
A comparison of direct microscopy, the concentration method and the Mycobacteria Growth Indicator Tube for the examination of sputum for acid-fast bacilli. Int J Tuberc Lung Dis (2003) 1.17
Interrelationship of active and latent secreted human cathepsin B precursors. Biochem J (1986) 1.17
The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide. Biochemistry (1999) 1.17
The control of pyruvate kinase of Escherichia coli. Binding of substrate and allosteric effectors to the enzyme activated by fructose 1,6-bisphosphate. Biochemistry (1976) 1.16
Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Biochemistry (1997) 1.16
Tyrosine 319 in the interdomain B of ZAP-70 is a binding site for the Src homology 2 domain of Lck. J Biol Chem (1999) 1.15
Link protein as a monitor in situ of endogenous proteolysis in adult human articular cartilage. Biochem J (1991) 1.15
Inflammatory cytokines induce synthesis and secretion of gro protein and a neutrophil chemotactic factor but not beta 2-microglobulin in human synovial cells and fibroblasts. Biochem J (1989) 1.15
Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design. J Biol Chem (1995) 1.14
Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. J Clin Invest (1992) 1.14
Potent slow-binding inhibition of cathepsin B by its propeptide. Biochemistry (1992) 1.13
Importance of hydrogen-bonding interactions involving the side chain of Asp158 in the catalytic mechanism of papain. Biochemistry (1991) 1.12
Activation of procathepsin B in human hepatoma cells: the conversion into the mature enzyme relies on the action of cathepsin B itself. Biochem J (1993) 1.12
Negative regulation of epidermal growth factor signaling by selective proteolytic mechanisms in the endosome mediated by cathepsin B. J Biol Chem (1999) 1.12
Constraints faced by sex workers in use of female and male condoms for safer sex in urban zimbabwe. J Urban Health (2001) 1.11
Stone formation by Ureaplasma urealyticum in human urine and its prevention by urease inhibitors. J Clin Microbiol (1984) 1.10
Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation. J Biol Chem (2001) 1.09
High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients. Bone Marrow Transplant (2000) 1.09
Characterization of a latent cysteine proteinase from ascitic fluid as a high molecular weight form of cathepsin B. Biochim Biophys Acta (1983) 1.09
Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms. Eur J Endocrinol (2011) 1.09
Defects in articular cartilage metabolism and early arthritis in fibroblast growth factor receptor 3 deficient mice. Hum Mol Genet (2006) 1.09
Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients. Neurology (2011) 1.08
A selective assay for endooligopeptidase A based on the cleavage of fluorogenic substrate structurally related to enkephalin. Biochem Biophys Res Commun (1990) 1.08
A latent thiol proteinase from ascitic fluid of patients with neoplasia. Biochim Biophys Acta (1981) 1.08
Non-proteoglycan forms of biglycan increase with age in human articular cartilage. Biochem J (1993) 1.08
Dynamic stiffness and crossbridge action in muscle. Biophys Struct Mech (1977) 1.08
Autocatalytic processing of the streptococcal cysteine protease zymogen: processing mechanism and characterization of the autoproteolytic cleavage sites. Eur J Biochem (1999) 1.08
Response of brainstem trigeminal neurons to electrical stimulation of the dura. Brain Res (1986) 1.07
The permeability barrier of Haemophilus influenzae type b against beta-lactam antibiotics. J Antimicrob Chemother (1983) 1.07
Characterization of recombinant rat cathepsin B and nonglycosylated mutants expressed in yeast. New insights into the pH dependence of cathepsin B-catalyzed hydrolyses. J Biol Chem (1992) 1.07
Human articular cartilage secretes characteristic metal dependent proteinases upon stimulation by mononuclear cell factor. J Rheumatol (1986) 1.05
Physiological properties of raphe magnus neurons during sleep and waking. J Neurophysiol (1999) 1.05
Serotonin immunoreactivity is contained in one physiological cell class in the rat rostral ventromedial medulla. J Neurosci (1994) 1.04
Biochemical and immunological studies of lysosomal and related proteinases in health and disease. J Histochem Cytochem (1981) 1.03
Presence of pro-forms of decorin and biglycan in human articular cartilage. Biochem J (1996) 1.03
Ageing and the aggregating proteoglycans of human articular cartilage. Clin Sci (Lond) (1986) 1.02
The specificity of the S1' subsite of cysteine proteases. FEBS Lett (1993) 1.02
Inhibition of urease activity by hydroxamic acid derivatives of amino acids. J Biochem (1975) 1.01
The action of human articular-cartilage metalloproteinase on proteoglycan and link protein. Similarities between products of degradation in situ and in vitro. Biochem J (1986) 1.01